SCHEMBL4714219

SCHEMBL4714219

CC(=O)Oc1cccnc1/C=C/c1cc(Cl)cc(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.45
TDP1 Q9NUW8 3/20 0.45
CYP3A4 P08684 2/20 0.45
ALOX12 P18054 1/20 0.45
NFE2L2 Q16236 3/20 0.39
KMT2A Q03164 6/20 0.39
MEN1 O00255 5/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MAPT P10636 5/20 0.38
LMNA P02545 4/20 0.38
TP53 P04637 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
TTR P02766 2/20 0.38
PDE5A O76074 1/20 0.38
HPGD P15428 3/20 0.37
NPSR1 Q6W5P4 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
MAPK1 P28482 2/20 0.37
NFKB1 P19838 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4714220 1.00 KDM4E (0.45) KDM4ETDP1CYP3A4ALOX12NFE2L2
SCHEMBL4710419 0.82 NFE2L2 (0.52) NFE2L2AHR
SCHEMBL4710418 0.82 NFE2L2 (0.52) NFE2L2AHR
SCHEMBL4711297 0.81 KDM4E (0.48) KDM4ETDP1CYP3A4ALOX12NFE2L2
SCHEMBL4790285 0.79 NFE2L2 (0.48) KDM4ETDP1CYP3A4ALOX12NFE2L2
SCHEMBL4790286 0.79 NFE2L2 (0.48) KDM4ETDP1CYP3A4ALOX12NFE2L2
SCHEMBL4710439 0.79 KMT2A (0.40) KDM4ETDP1CYP3A4KMT2AMEN1
SCHEMBL4710440 0.79 KMT2A (0.40) KDM4ETDP1CYP3A4KMT2AMEN1
SCHEMBL4712497 0.74 AHR (0.44) NFE2L2AHR
SCHEMBL4712494 0.74 AHR (0.44) NFE2L2AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0998459-A2 PYRIDINE DERIVATIVES Novartis AG (CH) 2000-05-10 EP claimed
WO-1999002497-A2 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 1999-01-21 WO claimed
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP disclosed